Technical Articles

基于TR-FRET技术的PCSK9靶向血脂调节药物研究进展
Research Progress on PCSK9-Targeted Lipid-Regulating Drugs Based on TR-FRET Technology
发布时间 2026-04-13
PCSK9 is a serine protease synthesized by the liver and responsible for regulating protein activity, first reported in 2003. In 2004, studies found that overexpression of PCSK9 in rodent experiments led to a reduction in LDL-R and an increase in LDL-C.
View details
  • Drug Research
  • TR-FRET Technology
  • PCSK9 (D347Y)/LDLR
  • Statin Drugs
Total 1
  • 1
Go to